Sign Up to like & get
recommendations!
1
Published in 2022 at "Computational Intelligence and Neuroscience"
DOI: 10.1155/2022/5266770
Abstract: Temozolomide (TMZ), an oral alkylating agent, is the widely used first-line chemotherapeutic reagent for glioma in clinical practice. However, TMZ-induced autophagy is another cellular process favoring glioma cell survival. This study aimed to explore whether…
read more here.
Keywords:
temozolomide tmz;
tmz induced;
hispidulin enhances;
glioma ... See more keywords